- Oxea Sarl: Fourth quarter highlights: - Net sales were EUR351.2 million, up 43% from the prior year period - Operating Result was EUR37.6 million versus EUR24.3 million in the prior year period - Net Income was EUR24.3 million versus EUR16.8 million in the prior year period - Adjusted EBITDA was EUR46.4 million versus EUR34.2 million in the prior year period
Oxea Sarl, a leading global supplier of Oxo Intermediates and Oxo Derivatives, today announced fourth quarter net sales of EUR351.2 million, a 43% increase from the same period last year.
Oxea's continued strong performance in the fourth quarter demonstrates the robustness of the business model. Recovery in the US and European regions coupled with continued strong demand from Asia contributed to another set of outstanding results. Q4 2010 Adjusted EBITDA at EUR46.4 million, and an Adjusted EBITDA margin of 13.2%, reflects an excellent performance for Oxea and underlines the continued strong relationships with customers and the valuable contribution of Oxea's employees to the success of the business. After the refinancing in July 2010, net debt has been reduced to approximately 2.1x EBITDA.
In EUR million - Unaudited Three months ended Twelve Months ended December 31, December 31, 2010 2009 2010 2009 Net Sales 351.2 246.2 1,365.3 888.0 Gross Profit 44.4 30.9 190.0 98.5 SG&A (11.0) (5.4) (46.9) (28.1) R&D (1.3) (1.1) (5.5) (3.7) Other operating income/(expense) 5.5 (0.1) 45.6 0.1 Operating Result 37.6 24.3 183.2 66.8 Net Income 24.3 16.8 111.1 28.2 Adjusted EBITDA 46.4 34.2 179.9 105.0
Sales for the three months ended December 31, 2010 were EUR351.2 million, a 43% increase compared with the corresponding period of the prior year. The increase was driven by an increase of 8% in total volumes, improved product mix and the pass through of higher raw material costs to customers. The volume increase was particularly strong in our Oxo Derivatives segment, where volumes were some 12% higher than in the prior year period. Volumes in the Intermediates segment were some 7% higher than in the prior year period. EUR183.2 million of our revenues for the three months ended December 31, 2010, resulted from sales in Europe, EUR103.3 million in NAFTA and EUR64.7 million in the rest of the world compared to EUR115.8 million, EUR77.8 million and EUR52.6 million respectively in the prior year period.
Gross profit for the three months ended December 31, 2010 increased by 44% to EUR44.4 million compared with EUR30.9 million in the corresponding period of the prior year. The increase of EUR13.5 million was attributable to higher volumes in both Oxo Intermediates and Derivatives segments and improved margins which more than offset the increase in raw materials and manufacturing fixed costs.
Selling general & administration expense (SG&A)
SG&A expense for the three months ended December 31, 2010 increased to EUR11.0 million compared with EUR5.4 million in the corresponding period of the prior year. The increase is primarily attributable to higher consulting fees in relation to projects, increased selling costs associated with higher volumes, and higher personnel costs including salary increases and accruals for employee bonuses.
Other operating income/(expense)
Net other operating income for the three months ended December 31, 2010 amounted to EUR5.5 million compared with EUR0.1 million net other operating expense in the corresponding period of the prior year. The increase is primarily attributable to increased income from site services, insurance proceeds and net foreign exchange gains.
Operating result for the three months ended December 31, 2010 was EUR37.6 million compared with EUR24.3 million in the corresponding period of the prior year period as a result of increased volumes and improved operating margins and higher other operating income partly offset by higher SG&A expense.
Net income for the three months ended December 31, 2010 was EUR24.3 million compared with EUR16.8 million in the corresponding period of the prior year as a result of the improvement in margins and higher sale volumes with a corresponding increase in operating profit and lower income taxes due to a reduced effective tax rate partly offset by higher interest expense arising from the refinancing in July 2010.
Adjusted EBITDA was EUR46.4 million compared with EUR34.2 million in the corresponding period of the prior year driven by the improved volumes and improved operating margins.
The company continued to generate positive free cash flow. In 2010 Oxea generated EUR135.6 million in cash from operating activities compared with EUR77.6 million in the prior year as a result of increased earnings and lower cash taxes which were partly offset by higher trade working capital. Cash provided by investing activities was EUR50.2 million compared with an utilisation of EUR22.3 million in the corresponding period of the prior year driven by proceeds from divestitures in the amount of EUR79.0 million partly offset by an increased level of capital expenditure. Cash used in financing activities was EUR178.2 million compared with EUR41.0 million in the corresponding period of the prior year whereby proceeds of some EUR505.7 million from the recent bond issue were used to repay existing bank debt and shareholder loans.
Oxea is a global manufacturer of Oxo intermediates and derivatives such as alcohols, polyols, carboxylic acids, specialty esters and amines. These products are sold in the merchant market (where sales are to third party customers) and used for the production of high-quality coatings, lubricants, cosmetics and pharmaceutical products, flavorings and fragrances, printing inks and plastics. In the 12 months ending December 2010, Oxea generated revenue of about EUR1.4 billion with approximately 1,330 employees in Europe, the Americas and Asia.
Forward looking statements
* This document contains financial information regarding the businesses and assets of OXEA S. r.l. (the "Company") and its consolidated subsidiaries (the "Group"). Such financial information has not been audited, reviewed or verified by any independent accounting firm. The inclusion of such financial information in this document or any related presentation should not be regarded as a representation or warranty by the Company, any of its respective affiliates, advisors or representatives or any other person as to the accuracy or completeness of such information<<s portrayal of the financial condition or results of operations by the Group.
* This document may contain information, data and predictions about our markets and our competitive position. While we believe this data to be reliable, it has not been independently verified, and we make no representation or warranty as to the accuracy or completeness of such information set forth in this document. Additionally, industry publications and reports from which such information, data or predictions may be obtained generally state that the information contained therein has been obtained from sources believed to be reliable but that the accuracy and completeness of such information is not guaranteed and in some instances state that they do not assume liability for such information. We cannot therefore assure you of the accuracy and completeness of such information and we have not independently verified such information. In addition, we have made statements in this document regarding our industry and position in the industry based on our experience and our own investigation of market conditions. We cannot assure you that the assumptions underlying these statements are accurate or correctly reflect the state and development of, or our position in,the industry, and none of our internal surveys or information has been verified by any independent sources.
* Certain statements in this document are forward-looking. By their nature, forward-looking statements involve known and unknown risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance. These factors include, among others: the cyclical and highly variable nature of our business and its sensitivity to changes in supply and demand; adverse and uncertain global economic conditions; the highly variable nature of raw materials costs and any loss of key suppliers or supply shortages or disruptions; the competitive nature of our industry; the ability to comply with current or future laws and regulations relating to environmental, health and safety matters as well as the safety of our products, related costs of maintaining compliance and addressing liabilities as well as risks relating to compliance with antitrust and tax laws; our reliance on a limited number of suppliers for certain of our key raw materials; operational risks, including the risk of environmental contamination and potential product liability claims; operational interruptions at our facilities due to events that are outside of our control such as severe weather conditions, unscheduled downtimes, terrorist attacks, natural disasters or other events that may interrupt or damage our operations or the impact of scheduled outages on our results of operations; the risk that our insurance coverage may not be sufficient to cover all risks; risks relating to the global nature of our operations, including, among others, fluctuations in exchange rates; the loss of major customers or key customers for certain of our products; the loss of key personnel; risks relating to acquisitions and dispositions, including any impairment risks with respect to historical acquisitions, our ability to successfully integrate acquired businesses, and unexpected liabilities relating to such acquisitions or contingent liabilities in connection with such dispositions; the requirement to make further contributions to our pension schemes; the failure to protect our intellectual property rights; limitations on our ability to adjust the quality of certain products that we manufacture; and potential conflicts of interests with our principal shareholder.
* These and other factors could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this document regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. New risks can emerge from time to time, and it is not possible for us to predict all such risks, nor can we assess the impact of all such risks on our business or the extent to which any risks, or combination of risks and other factors, may cause actual results to differ materially from those contained in any forward-looking statements. Neither the Company nor the Group undertakes any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You should not place undue reliance on forward-looking statements, which speak only as of the date of this document.
Use of non IFRS financial information:
* EBITDA is defined as net income for the year before financial result, income taxes, depreciation and amortization. EBITDA, is a supplemental measure of our performance and liquidity that is not required by or presented in accordance with IFRS. EBITDA is not a measurement of our financial performance or liquidity under IFRS and should not be considered as an alternative to profit for the period presented, results from operating activities or any other performance measures derived in accordance with IFRS or as an alternative to cash flow from operating activities as a measure of our liquidity. We believe EBITDA facilitates operating performance comparisons from period to period and company to company by eliminating potential differences caused by variations in capital structures (affecting interest expense), tax positions (such as the impact on periods or companies of change in effective tax rates or net operating losses) and the age and book value and amortization of tangible and intangible assets (which have an effect on related depreciation expense). We also present EBITDA because we believe it is frequently used by securities analysts, investors and other interested parties in the evaluation of similar issuers, the majority of which present EBITDA when reporting their results. Finally, we present EBITDA as a measure of our ability to service our debt.
* Adjusted EBITDA is defined as EBITDA adjusted to remove the effects of certain non-cash and non-recurring expenses and charges. Adjusted EBITDA is a supplemental measure of our performance and liquidity that is not required by or presented in accordance with IFRS. Adjusted EBITDA is not a measurement of our financial performance or liquidity under IFRS and should not be considered as an alternative to profit for the period presented, results from operating activities or any other performance measures derived in accordance with IFRS or as an alternative to cash flow from operating activities as a measure of our liquidity. We believe Adjusted EBITDA facilitates operating performance comparisons from period to period and company to company by eliminating certain non-recurring expenses and charges. We also present Adjusted EBITDA because we believe it is frequently used by securities analysts, investors and other interested parties in the evaluation of similar issuers. Finally, we present Adjusted EBITDA as a measure of our ability to service our debt.
Further inquiry note: Neil Robertson Managing Director (Finance, IT) email@example.com Birgit Reichel Global Communications firstname.lastname@example.org Oxea GmbH Otto-Roelen-Strasse 3 D-46147 Oberhausen http://www.oxea-chemicals.com company: Oxea GmbH Otto-Roelen-Strase 3 D-46147 Oberhausen phone: +49(0)208 693 3112 FAX: +49(0)208 693 3101 mail: email@example.com WWW: http://www.oxea-chemicals.com sector: Chemicals ISIN: XS0523636594 indexes: stockmarkets: Open Market: Frankfurt
SOURCE Oxea GmbH